Lamictal Chewable Dispersible Tablets
Company: GlaxoWellcome
Approval Status: Approved August 1998
Treatment for: Epilepsy
Areas: Neurology
Possible similar drugs: Lamictal
General Information
Other Useful Resources
Lamictal tablets are used for the treatment of Lennox-Gastaut syndrome seizures of patients with severe forms of epilepsy.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
